FOXO Stock Overview Develops epigenetic biomarkers technology solutions in the United States. More details
Rewards Risk Analysis + 1 more risk
See All Risk Checks Capture your thoughts, links and company narrative
FOXO Technologies Inc. Competitors Price History & Performance
Summary of share price highs, lows and changes for FOXO Technologies Historical stock prices Current Share Price US$0.28 52 Week High US$1.30 52 Week Low US$0.13 Beta 3.39 1 Month Change -47.80% 3 Month Change 45.60% 1 Year Change 5.64% 3 Year Change -99.72% 5 Year Change n/a Change since IPO -99.72%
Recent News & Updates
Foxo Technologies Inc. Appoints Seamus Lagan as Chief Executive Officer Dec 11 FOXO Technologies Inc. announced that it has received $0.22 million in funding Dec 05
FOXO Technologies Inc. announced that it has received $0.22 million in funding Dec 04
FOXO Technologies Inc. announced delayed 10-Q filing Nov 15
Less than half of directors are independent Nov 14 FOXO Technologies Inc. announced that it has received $0.297033 million in funding from Kr8 ai Inc. Oct 29
See more updates
Foxo Technologies Inc. Appoints Seamus Lagan as Chief Executive Officer Dec 11 FOXO Technologies Inc. announced that it has received $0.22 million in funding Dec 05
FOXO Technologies Inc. announced that it has received $0.22 million in funding Dec 04
FOXO Technologies Inc. announced delayed 10-Q filing Nov 15
Less than half of directors are independent Nov 14 FOXO Technologies Inc. announced that it has received $0.297033 million in funding from Kr8 ai Inc. Oct 29
FOXO Technologies Inc. announced that it has received $0.2565 million in funding Oct 28
FOXO Technologies Inc. (NYSEAM:FOXO) completed the acquisition of Rennova Community Health, Inc. from Rennova Health, Inc.(OTCPK:RNVA) for $20 million. Sep 18
FOXO Technologies Inc. announced delayed 10-Q filing Aug 15
FOXO Technologies Regains Compliance with NYSE American Aug 09
FOXO Technologies Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Reaffirms Commitment to Regaining Compliance with NYSE American Jul 17
Less than half of directors are independent Jul 01 FOXO Technologies Inc. (NYSEAM:FOXO) entered into the Stock Exchange Agreement to acquire Myrtle Recovery Centers from Rennova Health, Inc. (OTCPK:RNVA) for $0.5 million.
FOXO Technologies Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements Apr 26 FOXO Technologies Inc. announced delayed annual 10-K filing Apr 02
FOXO Technologies Inc. announced that it has received $0.1422 million in funding Mar 21
FOXO Technologies Inc. (NYSEAM:FOXO) entered into a non-binding agreement to acquire M2i Global, Inc. (OTCPK:MTWO). Feb 16
FOXO Technologies Inc. (NYSEAM:FOXO) entered into a non-binding agreement to acquire M2i Global, Inc. (OTCPK:MTWO). Feb 15
Less than half of directors are independent Feb 15 FOXO Technologies Inc. announced that it has received $0.45747 million in funding Feb 13
FOXO Technologies Inc. Announces Appointment of Francis Colt Dewolf to the Board of Directors
FOXO Technologies Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements Dec 19
FOXO Technologies Inc. Announces the Resignation of Andrew Poole from the Board of Directors Nov 29
FOXO Technologies Inc. Announces the Resignation of Andrew Poole from the Board of Directors Nov 28
FOXO Technologies Inc. announced delayed 10-Q filing Nov 17
FOXO Technologies Inc. Plans to Unveil its New Direct-To-Consumer (DTC) App, the VITHAR™ AI Health Coach Nov 09
FOXO Technologies Inc. Unveils Plans for New Direct-To Consumer Offering Combining the Company's Epigenetic Data with the Power of Ai Oct 31
High number of new and inexperienced directors Oct 22
FOXO Technologies Inc. Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers Oct 14 FOXO Technologies Inc. Appoints Martin Ward as Interim Chief Financial Officer FOXO Technologies Inc. announced that it has received $0.7435 million in funding Sep 13
FOXO Technologies Inc. announced that it has received $0.2935 million in funding Sep 08
FOXO Technologies Announces NYSE American Acceptance of Compliance Plan Sep 02
FOXO Technologies Announces NYSE American Acceptance of Compliance Plan Sep 01 FOXO Technologies Inc. announced that it expects to receive $0.2935 million in funding Aug 24
FOXO Technologies Announces Receipt of Second Notice of Non-Compliance from NYSE American Aug 21
FOXO Technologies Inc. to Report Q2, 2023 Results on Aug 10, 2023 Aug 09
FOXO Technologies Inc. Reduces Employee Headcount via Layoffs Jul 23
FOXO Technologies Inc. Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis Jul 22
New major risk - Market cap size Jul 09
FOXO Technologies Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements Jun 17 FOXO Technologies Inc. announced that it has received $3.806125 million in funding Jun 09
First quarter 2023 earnings released: US$0.33 loss per share (vs US$6.09 loss in 1Q 2022) May 13
FOXO Technologies Inc., Annual General Meeting, May 26, 2023 May 05
Full year 2022 earnings released: US$3.46 loss per share (vs US$19.06 loss in FY 2021) Apr 02
High number of new and inexperienced directors Feb 17
FOXO Technologies Inc. Appoints Taylor Fay as Chief Operating Officer Feb 04
Foxo Technologies Inc. Announces Resignation of Jon Sabes as Member of the Board of Directors Feb 03 FOXO Technologies Inc. announced delayed 10-Q filing
Less than half of directors are independent Nov 16
FOXO Technologies Announces Resignation of Chief Product Officer, Erin Sharoni Nov 15
FOXO Technologies Inc. to Report Q3, 2022 Results on Nov 14, 2022 Nov 08 Shareholder Returns FOXO US Software US Market 7D -37.6% -2.2% -2.4% 1Y 5.6% 22.4% 23.4%
See full shareholder returns
Return vs Industry: FOXO underperformed the US Software industry which returned 22.4% over the past year.
Return vs Market: FOXO underperformed the US Market which returned 23.4% over the past year.
Price Volatility Is FOXO's price volatile compared to industry and market? FOXO volatility FOXO Average Weekly Movement 136.4% Software Industry Average Movement 7.9% Market Average Movement 6.3% 10% most volatile stocks in US Market 16.8% 10% least volatile stocks in US Market 3.1%
Stable Share Price: FOXO's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: FOXO's weekly volatility has increased from 70% to 136% over the past year.
About the Company FOXO Technologies Inc. develops epigenetic biomarkers technology solutions in the United States. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness, and aging. It offers FOXO Labs, a commercializing proprietary epigenetic biomarker technology enables the adoption of saliva-based health and wellness biomarker solutions for underwriting and risk assessment; and Bioinformatics services that provides data solutions using AI and machine learning for data analysis and processing, and quality checking for academia, healthcare, government, and pharmaceutical research customers.
Show more FOXO Technologies Inc. Fundamentals Summary How do FOXO Technologies's earnings and revenue compare to its market cap? FOXO fundamental statistics Market cap US$4.91m Earnings (TTM ) -US$10.53m Revenue (TTM ) US$1.34m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) FOXO income statement (TTM ) Revenue US$1.34m Cost of Revenue US$634.00k Gross Profit US$707.00k Other Expenses US$11.23m Earnings -US$10.53m
Last Reported Earnings
Sep 30, 2024
Earnings per share (EPS) -0.60 Gross Margin 52.72% Net Profit Margin -784.94% Debt/Equity Ratio -179.8%
How did FOXO perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2024/12/22 03:44 End of Day Share Price 2024/12/20 00:00 Earnings 2024/09/30 Annual Earnings 2023/12/31
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources FOXO Technologies Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
